JAK Inhibitor Overview and Relevance to AD

Opinion
Video

Christopher Bunick, MD, PhD, and Ruth Ann Vleugels, MD, MPD, MBA, discuss the method of action for Janus Kinase (JAK) inhibitors and the pathology of atopic dermatitis (AD).

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.